In addition to Pfizer and Moderna's new formulas, Novavax's protein-based shot is an option for COVID vaccination this season ...

A large team of microbiologists, pathologists and infectious diseases specialists affiliated with several institutions in the ...

A now-defunct Canadian company was trying to produce vaccine components in vegetables, not add vaccines to the produce found ...

The retrospective study presented at ESMO 2024 involved about 2,400 patients with stage 3 or 4 non-small cell lung cancer.

Which COVID vaccine is better of the Pfizer, Modern and Novavax options? Here's how they compare with safety and efficacy and ...

The bacterium Clostridioides difficile is named “difficult” for a reason. Originally, it was hard to grow in the lab, and, ...

An mRNA vaccine that targets several aspects of C. difficile’s ability to cause severe disease prevented major symptoms and death in mice.

“The 12-month results from the ARCT-154 study continue to establish the durability of immune response from this self-amplifying mRNA vaccine and reinforce the ability of this vaccine to provide ...

Three-year Spanish study of nearly 1,000 patients draws little attention outside doctors, journalists who have long warned of ...

The newest update to the COVID-19 vaccine reached pharmacies as infections in Indiana began to rise. Members of our audience ...

Head-to-head data, presented at OPTIONS XII for the Control of Influenza Conference, demonstrates advantage of sa-mRNA over conventional mRNA in duration of immune response; Results highlight CSL ...